Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study,Amyloid

当前位置： X-MOL 学术 › Amyloid › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study
Amyloid ( IF 5.5 ) Pub Date : 2023-07-20 , DOI: 10.1080/13506129.2023.2232520
Simina Ticau ₁ , Emre Aldinc ₁ , Michael Polydefkis ₂ , David Adams ₃ , Teresa Coelho ₄ , Mitsuharu Ueda ₅ , Cecilia Hale ₁ , John Vest ₁ , Paul Nioi ₁ ,

Affiliation

Longitudinal changes in neurofilament light chain (NfL) levels were evaluated alongside prespecified clinical assessments 24 months into the patisiran Global open-label extension (OLE) study in pat...

中文翻译：